Wipro positioned as a Leader in IDC MarketScape: Worldwide Life Science Drug Safety Services 2019-2020 Vendor Assessment

The life science drug safety services (DSS) market is growing rapidly as drug safety (DS) adverse events (AEs) continue to increase by 30–50% annually. Most life science companies actively rely on proven industry-specific service providers to deliver their drug safety services needs in an area routinely classified as noncore to the business. 

Leadership in this study is based on foundational drug safety services capabilities, broad current DSS market presence, current and planned investment in DSS innovation, and other related innovation investment, with a view toward both today's evolving needs and looking forward over the next three to five years.

After a close evaluation of Wipro's drug safety services strategies and capabilities, IDC has positioned the company in the Leaders category within this 2019–2020 IDC MarketScape for building innovation in worldwide drug safety services.